A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a
NCT03298360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2020-12-08
Summary
To analyze the HIV viral sequences present in the CD32 + CD4a + T lymphocytes of the patients who have participated in the ANRS 139 TRIO trial, always followed and in virological success, and carrying multi-resistant viruses archived in the HIV cell reservoir, in order to reconstruct the chronology of the installation of this reservoir.
Conditions
- HIV Infections
Interventions
- OTHER
-
Blood sample
167mL of blood in EDTA tube will be obtained on a research visit, after signature of written informed consent
Sponsors & Collaborators
-
ANRS, Emerging Infectious Diseases
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-28
- Primary Completion
- 2019-06-25
- Completion
- 2020-06-25
Countries
- France
Study Locations
More Related Trials
-
Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)
NCT00120185 ·Status: COMPLETED ·Phase: PHASE2
-
Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection
NCT00859677 ·Status: COMPLETED
-
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3
NCT00000779 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers
NCT00027482 ·Status: COMPLETED
-
Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials
NCT00789789 ·Status: TERMINATED
-
Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants
NCT03735849 ·Status: COMPLETED ·Phase: PHASE1
-
Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV
NCT03837756 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
NCT01376726 ·Status: COMPLETED ·Phase: PHASE1
-
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
NCT00029445 ·Status: RECRUITING
-
Lipopeptide Immunisation With GTU-multiHIV Trial
NCT01492985 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells
NCT03856996 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Responses to Two Experimental HIV Vaccines in Healthy Adults
NCT01386489 ·Status: COMPLETED ·Phase: PHASE1
-
Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
NCT00440206 ·Status: COMPLETED
-
Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)
NCT00113282 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Cure Study of Anti-PD-L1 Antibody ASC22 in Combination With Chidamide in HIV-infected Patients With Antiviral Suppression
NCT05129189 ·Status: UNKNOWN ·Phase: PHASE2
-
Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV Remission Without Antiretrovirals
NCT06805656 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected Individuals
NCT05786937 ·Status: UNKNOWN ·Phase: PHASE1
-
Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients
NCT00333892 ·Status: COMPLETED
-
Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection
NCT00050284 ·Status: COMPLETED
-
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
NCT00002359 ·Status: COMPLETED ·Phase: PHASE3
-
FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir
NCT01777997 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
NCT05719441 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)
NCT02411539 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immune Response to a Clade C DNA HIV Vaccine
NCT02997969 ·Status: COMPLETED ·Phase: PHASE1
-
X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study
NCT01952587 ·Status: COMPLETED ·Phase: NA